Michael Bigham, Executive Chairman of the Board at Paratek Pharmaceuticals, Inc. (PRTK), sold 64,060 shares at $5.12 ($328K) on 2021-08-17, disclosed to the SEC on 2021-08-18.
Open-market sale of $328k PRTK by Executive Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.12 | 32,030 | $164K | 50.0% |
| 2 | $5.12 | 32,030 | $164K | 50.0% |
| Total | $5.12 avg | 64,060 | $328K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |